MMP9 and intracranial hemorrhage: These cells interact with vascular endothelial cells at the injury site, promoting the release of free oxygen radicals and matrix metalloproteinase-9 (MMP-9), which subsequently leads to intracranial hemorrhage transformation, early neurological deterioration, and malignant brain edema, among other adverse reactions, resulting in poor patient outcomes (46–49).